Fingolimod Modulates Peripheral Effector and Regulatory T Cells in MS Patients
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Fingolimod Modulates Peripheral Effector and Regulatory T Cells in MS Patients
Authors
Keywords
Multiple sclerosis, T cells, IL-17, IFNγ, S1P, Fingolimod
Journal
Journal of Neuroimmune Pharmacology
Volume 8, Issue 5, Pages 1106-1113
Publisher
Springer Nature
Online
2013-05-06
DOI
10.1007/s11481-013-9465-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CD39 is highly involved in mediating the suppression activity of tumor-infiltrating CD8+ T regulatory lymphocytes
- (2013) Alessia Parodi et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Sphingosine-1-Phosphate and Lymphocyte Egress from Lymphoid Organs
- (2012) Jason G. Cyster et al. Annual Review of Immunology
- Rarity of Human T Helper 17 Cells Is due to Retinoic Acid Orphan Receptor-Dependent Mechanisms that Limit Their Expansion
- (2012) Veronica Santarlasci et al. IMMUNITY
- IL-17A secretion by CD8+ T cells supports Th17-mediated autoimmune encephalomyelitis
- (2012) Magdalena Huber et al. JOURNAL OF CLINICAL INVESTIGATION
- Defining the human T helper 17 cell phenotype
- (2012) Francesco Annunziato et al. TRENDS IN IMMUNOLOGY
- Evidence of the transient nature of the Th17 phenotype of CD4+CD161+ T cells in the synovial fluid of patients with juvenile idiopathic arthritis
- (2011) Lorenzo Cosmi et al. ARTHRITIS AND RHEUMATISM
- CD161highCD8+T cells bear pathogenetic potential in multiple sclerosis
- (2011) Viviana Annibali et al. BRAIN
- Alteration of Th17 and Treg cell subpopulations co-exist in patients affected with systemic sclerosis
- (2011) Daniela Fenoglio et al. CLINICAL IMMUNOLOGY
- Haplotype 4 of the multiple sclerosis-associated interleukin-7 receptor alpha gene influences the frequency of recent thymic emigrants
- (2010) B Broux et al. GENES AND IMMUNITY
- Th17 central memory T cells are reduced by FTY720 in patients with multiple sclerosis
- (2010) M. Mehling et al. NEUROLOGY
- A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis
- (2010) Ludwig Kappos et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
- (2010) Jeffrey A. Cohen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pathogenic CD8+T cells in multiple sclerosis
- (2009) Manuel A. Friese et al. ANNALS OF NEUROLOGY
- Preferential recruitment of interferon-γ-expressing TH17 cells in multiple sclerosis
- (2009) Hania Kebir et al. ANNALS OF NEUROLOGY
- Phenotypical and functional characterization of T helper 17 cells in multiple sclerosis
- (2009) Verena Brucklacher-Waldert et al. BRAIN
- Cutting Edge: Phenotypic Characterization and Differentiation of Human CD8+ T Cells Producing IL-17
- (2009) T. Kondo et al. JOURNAL OF IMMUNOLOGY
- C-C chemokine receptor 6–regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE
- (2009) Andrea Reboldi et al. NATURE IMMUNOLOGY
- Regulatory T cells exert checks and balances on self tolerance and autoimmunity
- (2009) Kajsa Wing et al. NATURE IMMUNOLOGY
- Human interleukin 17–producing cells originate from a CD161+CD4+T cell precursor
- (2008) Lorenzo Cosmi et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Multiple sclerosis
- (2008) Alastair Compston et al. LANCET
- FTY720 therapy exerts differential effects on T cell subsets in multiple sclerosis
- (2008) M. Mehling et al. NEUROLOGY
- Interleukin-17 Production in Central Nervous System-Infiltrating T Cells and Glial Cells Is Associated with Active Disease in Multiple Sclerosis
- (2007) John S. Tzartos et al. AMERICAN JOURNAL OF PATHOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now